ANIP
ANI Pharmaceuticals Inc
74.40$
-4.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | -1,214,500.0% | – | – | – | – | – | – | – | – | – | 10.9% | 11.5% | 398.4% | 33.2% | 20.5% | 16.6% | 37.9% | 44.7% | 36.2% | 30.6% | 41.8% | 46.5% | 43.9% | 37.3% | 40.7% | 49.0% | |
| 100.0% | 100.0% | 1,214,600.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 89.1% | 88.5% | -298.4% | 66.8% | 79.5% | 83.4% | 62.1% | 55.3% | 63.8% | 69.4% | 58.2% | 53.5% | 56.1% | 62.7% | 59.3% | 51.0% | |
| 1,137.8% | 66,058,800.0% | 94,391,600.0% | 122.6% | 168.9% | 5,636.3% | 11,763.9% | 2,480.8% | 26.7% | 963.6% | 417.6% | 1,087.4% | 1,604.8% | 10,153.1% | 734.1% | 5.7% | 4.8% | 3.8% | 2.3% | 5.1% | 7.6% | 9.6% | 7.7% | 5.3% | 7.1% | 7.0% | 7.3% | 5.8% | |
| 904.1% | 85,338,900.0% | 83,929,050.0% | 131.5% | 62.3% | 3,553.1% | 3,954.7% | 1,180.8% | 48.7% | 878.5% | 157.7% | 451.0% | 240.1% | 1,604.4% | 357.7% | 54.5% | 32.0% | 27.7% | 21.6% | 17.9% | 21.9% | 27.0% | 31.2% | 39.0% | 40.4% | 30.9% | 40.6% | 36.0% | |
| 2,261.1% | 160,494,200.0% | 184,460,150.0% | 259.4% | 234.5% | 9,331.3% | 15,849.5% | 3,700.6% | 76.2% | 1,860.3% | 576.4% | 3,154.4% | 1,851.6% | 11,791.5% | 1,107.1% | 63.9% | 43.8% | 40.5% | 41.3% | 38.8% | 46.2% | 61.5% | 65.9% | 71.9% | 67.3% | 53.1% | 59.2% | 41.8% | |
| -2,161.1% | -160,494,100.0% | -183,245,550.0% | -159.4% | -134.5% | -9,231.3% | -15,749.5% | -3,600.6% | 23.8% | -1,760.3% | -476.4% | -3,054.4% | -1,762.5% | -11,703.0% | -1,007.1% | 3.0% | 35.7% | 42.8% | 15.6% | 16.0% | 17.5% | 7.9% | -7.7% | -18.4% | -11.2% | 9.6% | 0.1% | 9.2% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 11.7% | 27.8% | 156.6% | 15.1% | 1.6% | 1.4% | 14.4% | 8.8% | 6.8% | 7.3% | 6.3% | 4.5% | 5.5% | 8.9% | 5.5% | 2.9% | 2.3% | |
| – | – | – | -149.4% | -134.5% | -9,099.1% | -15,427.9% | -3,735,629.4% | 19,332.0% | -1,538,256.5% | -460,882.5% | -3,777,879.8% | -1,867,089.4% | -11,859,661.7% | -1,210.0% | 0.4% | 34.6% | 28.5% | 6.7% | 9.2% | 9.9% | 1.5% | -12.5% | -25.9% | -19.8% | 4.1% | -3.6% | 10.8% | |
| – | -19,868,200.0% | -11,385,800.0% | – | – | – | – | 135.0% | 4.5% | -1,536,718.2% | -460,421.6% | 723.5% | 104.6% | 156.6% | -5.3% | 0.1% | -16.7% | 8.3% | 3.7% | 9.9% | 2.3% | -1.4% | -1.6% | -6.2% | -4.7% | 0.2% | -0.6% | 2.0% | |
| -2,161.1% | -140,625,900.0% | -171,859,750.0% | -149.4% | -134.5% | -9,099.1% | -15,427.9% | -3,735.6% | 19.3% | -1,538.3% | -460.9% | -3,777.9% | -1,867.1% | -11,859.7% | -1,204.7% | 1.0% | 51.4% | 20.1% | 3.1% | -0.6% | 7.7% | 3.0% | -10.8% | -19.7% | -15.1% | 3.9% | -3.0% | 8.9% | |
| -2,047.5% | -151,397,600.0% | -165,720,250.0% | -153.1% | -131.2% | -9,089.4% | -15,297.1% | -3,696.6% | 24.6% | -1,520.0% | -459.7% | -3,755.3% | -1,832.5% | -11,669.0% | -1,183.6% | 25.0% | 43.0% | 51.9% | 43.8% | 32.3% | 34.3% | 29.4% | 13.5% | 1.4% | 7.9% | 21.9% | 10.3% | 23.5% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.